RPL5 and cancer: In total, 139 RPL5 mutations and 74 different cancer-associated RPL11 mutations have been detected across 49 cancer types; these genes were found to be mutated in 34% of breast cancers, 28% of melanomas, and up to 34% of multiple myelomas in a comprehensive analysis of 19,000 cancer samples.